By Matthew Perlman ( March 15, 2023, 5:42 PM EDT) -- An upcoming trial on claims accusing Merck and Glenmark of conspiring to delay generic competition for the cholesterol medication Zetia will include only one phase after a Virginia federal judge rejected a bid from retailers for a three-phase, two-jury process....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.